Fifth Third Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1M Buy
25,068
+1,510
+6% +$1.54M 0.84% 20
2026
Q1
$21.7M Buy
23,558
+4,596
+24% +$4.66M 0.73% 22
2025
Q4
$20.4M Buy
18,962
+419
+2% +$401K 0.71% 24
2025
Q3
$14.1M Buy
18,543
+1,148
+7% +$854K 0.52% 32
2025
Q2
$13.6M Buy
17,395
+2,190
+14% +$1.7M 0.57% 31
2025
Q1
$12.6M Buy
15,205
+1,918
+14% +$1.6M 0.65% 25
2024
Q4
$10.3M Buy
13,287
+1,694
+15% +$1.4M 0.56% 28
2024
Q3
$10.3M Buy
11,593
+1,810
+19% +$1.63M 0.63% 22
2024
Q2
$8.86M Buy
9,783
+2,247
+30% +$1.8M 0.67% 21
2024
Q1
$5.86M Buy
7,536
+746
+11% +$531K 0.91% 17
2023
Q4
$3.96M Buy
6,790
+595
+10% +$347K 1.29% 14
2023
Q3
$3.33M Buy
6,195
+3,295
+114% +$1.7M 1.34% 14
2023
Q2
$1.36M Buy
2,900
+2,028
+233% +$850K 0.88% 34
2023
Q1
$299K Buy
+872
New +$294K 0.55% 61

Other funds holding LLY

Fifth Third Wealth Advisors's LLY Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Eli Lilly (LLY) stake by 6.4% in Q2 2026, buying an estimated $1.54M and bringing the position to 25,068 shares worth $30.1M. The position accounts for 0.84% of the portfolio, ranked #20.

Fifth Third Wealth Advisors first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fifth Third Wealth Advisors held 25,068 shares of Eli Lilly worth $30.1M as of Q2 2026.
  • Fifth Third Wealth Advisors bought 1,510 Eli Lilly shares in Q2 2026, an estimated $1.54M.
  • Eli Lilly made up 0.84% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #20 holding.
  • Fifth Third Wealth Advisors first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.